Skip to main content

ClearPoint Neuro, Inc.

CLPT
Exchange
Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
SEC CIK
0001285550

No open-market purchases or sales by ClearPoint Neuro, Inc. insiders were filed in the last 90 days; 129 institutions reported holding it in 13F filings for Q2 2026, worth $247.9M in total; no superinvestor holds it.

Key figures

Market capClose on Nov 16, 2026
$266.1M
Insider buysOpen market, last 90 days
0
Insider sellsOpen market, last 90 days
0
13F holdersQ2 2026, +11 vs. previous quarter
129
13F valueReported value at the end of Q2 2026
$247.9M
Superinvestors holdingAt the end of Q2 2026
0

Price chart

From SEC filings, in USD.

Revenue, FY2025
$37.0M
+17.8% year over year
Net income, FY2025
-$25.5M
No comparable prior period
Free cash flow, FY2025
-$24.4M
No comparable prior period
Revenue, Q3 FY2026
$12.1M
+36.3% year over year

Revenue flow, FY2025

Green is profit; orange is costs, expenses and taxes. Percentages are shares of revenue.

Net loss for FY2025: $25.5M (69.1% of revenue).

Short interest

See short data

From FINRA, settlement date Oct 30, 2026.

Short interest
4.29M
Shares sold short
Change
−334.6K
−7.2% vs. previous
Days to cover
6.56
At average daily volume

Superinvestors holding CLPT, Q2 2026

Go to the superinvestors tab

No superinvestor reported holding CLPT at the end of Q2 2026.

Latest insider trades

See all insider trades

Open-market purchases and sales by ClearPoint Neuro, Inc. insiders from Form 4, newest first.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Jul 1, 2026 (view filing)6:43 PM ETJun 292 daysBurnett Joseph MichaelCEO and PresidentSSale−20.0K$19.38−$387.6K−14.6%116.8K after10b5-1
Jun 22, 2026 (view filing)Jun 175 daysBurnett Joseph MichaelCEO and PresidentSSale−60.0K$17.79−$1.07M−33.9%116.8K after10b5-1
Jun 22, 2026 (view filing)Jun 175 daysBurnett Joseph MichaelCEO and PresidentSSale−1.84K$17.94−$33.1K−1.0%191.4K after10b5-1
Jun 2, 2026 (view filing)Jun 11 dayRichards Timothy T.DirectorSSale−5.42K$12.17−$65.9K−5.8%87.2K after
May 26, 2026 (view filing)May 215 daysKlein Matthew B.DirectorSSale−16.0K$11.59−$185.4K−25.4%46.9K after
May 21, 2026 (view filing)May 201 dayFallon Lynnette CDirectorSSale−5.09K$11.14−$56.7K−9.5%48.2K after10b5-1
Feb 26, 2026 (view filing)Feb 251 dayBurnett Joseph MichaelCEO and PresidentSSale−20.0K$15.17−$302.7K−9.4%193.2K after10b5-1
Jan 27, 2026 (view filing)Jan 261 dayBurnett Joseph MichaelCEO and PresidentSSale−2.94K$15.57−$45.8K−1.4%214.1K after10b5-1
Jan 13, 2026 (view filing)Jan 94 daysBurnett Joseph MichaelCEO and PresidentSSale−20.0K$16.12−$322.4K−63.4%11.6K after10b5-1
Oct 14, 2025 (view filing)Oct 104 daysBurnett Joseph MichaelCEO and PresidentSSale−26.5K$26.98−$714.0K−10.9%217.1K after4 lots10b5-1

Top 10 13F holders, Q2 2026

See all 129 holders

The largest institutional positions in ClearPoint Neuro, Inc. at the end of Q2 2026; share changes are against Q1 2026.

Institutions holding CLPT in Q2 2026
InstitutionSharesValue% of portfolioChange in sharesAction
BlackRock, Inc.2,379,804$42.5M0.00%+297,054+14.3%Added
Mak Capital One LLC2,375,861$42.4M5.94%+474,372+24.9%Added
Vanguard Capital Management LLC1,232,807$22.0M0.00%−10,808−0.9%Reduced
State Street Corp816,547$14.6M0.00%+136,728+20.1%Added
Geode Capital Management, LLC749,932$13.4M0.00%+44,212+6.3%Added
Lane Generational LLC444,831$7.94M6.97%−42,018−8.6%Reduced
UBS Group AG428,632$7.65M0.00%−3,728−0.9%Reduced
Millennium Management LLC357,676$6.38M0.00%+125,702+54.2%Added
Brown Advisory Inc325,906$5.81M0.01%00.0%Unchanged
Compass Financial Management LLC295,680$5.27M0.64%+295,680New

Holders of 5% or more of CLPT

See all 4 holders and filings

Holders whose latest Schedule 13D or 13G filing reports 5% or more of ClearPoint Neuro, Inc..

Largest holders of CLPT from 13D and 13G filings
HolderLatest formStakeChangeFirst filedLatest filingFiling
Bigger Capital Fund L P13G/A8.12%2.60M shares+0.67 ppfrom 7.45%Jun 9, 202111 filingsNov 3, 2026SEC
Mak Capital One LLC13G/A7.80%2.38M shares–Aug 12, 20261 filingAug 12, 2026SEC
BlackRock, Inc.13G/A7.10%2.12M shares+1.50 ppfrom 5.60%Jul 17, 20252 filingsJul 27, 2026SEC
MAK Capital Fund LP13G/A6.30%1.90M shares+0.20 ppfrom 6.10%Mar 13, 20262 filingsMay 15, 2026SEC